New studies continue to explore sildenafil’s role in cancer research, adding to growing scientific interest in the well-known medication.
United States, 7th Aug 2026 — Sildenafil has long been recognized as a trusted treatment for erectile dysfunction, but researchers are increasingly investigating whether the medication may have applications beyond its traditional use. Recent scientific studies have examined sildenafil’s effects on cancer cells, particularly in colorectal cancer, where researchers have identified mechanisms suggesting the drug may interfere with cholesterol metabolism and cellular processes involved in tumor growth and metastasis.
One recently published study found that PDE5 inhibitors such as sildenafil disrupted cholesterol trafficking within cancer cells by affecting the NPC1 cholesterol transport pathway, reducing the availability of cholesterol needed for cancer cell migration and metastasis. Researchers also observed that combining sildenafil with statins produced additive anti-metastatic effects in preclinical models, though they emphasized that additional clinical research is needed before these findings could translate into standard patient care.
Earlier laboratory research likewise demonstrated that sildenafil inhibited the growth of human colorectal cancer cells in both cell culture and animal models by promoting cell-cycle arrest and programmed cell death. While promising, these findings remain preclinical, and sildenafil is not approved by the U.S. Food and Drug Administration as a treatment for cancer.
“Medicine is constantly evolving, and one of the most exciting areas of research is discovering new therapeutic possibilities for medications that physicians have safely prescribed for years,” said a spokesperson for All Family Pharmacy. “While sildenafil should not be viewed as a cancer treatment, it’s encouraging to see researchers continue exploring its potential in new areas.”
All Family Pharmacy offers physician-guided access to sildenafil through its secure telehealth platform. Patients complete an online medical questionnaire that is reviewed by a licensed physician, and if medically appropriate, prescriptions are delivered directly to the patient’s home.
Patients interested in sildenafil for its FDA-approved indications can learn more or begin the physician review process by visiting AllFamilyPharmacy.com.
Read the Research
Sildenafil Inhibits the Growth of Human Colorectal Cancer In Vitro and In Vivo (National Institutes of Health):
https://pmc.ncbi.nlm.nih.gov/articles/PMC4697679/
PDE5α Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking (PubMed):
https://pubmed.ncbi.nlm.nih.gov/42446922/
About All Family Pharmacy
All Family Pharmacy is a family-owned telehealth pharmacy dedicated to making healthcare more accessible through physician-guided online consultations, affordable medications, and exceptional customer support. Patients receive personalized care from licensed healthcare professionals, with prescriptions shipped directly to their homes when medically appropriate.
Visit www.allfamilypharmacy.com for more.
Media Contact
Organization: All Family Pharmacy
Contact Person: Michael Kuenzler
Website: https://allfamilypharmacy.com/
Email: Send Email
Country:United States
Release id:47967
The post All Family Pharmacy Highlights Emerging Research on Sildenafil’s Potential Beyond Erectile Dysfunction appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Stocks Talent journalist was involved in the writing and production of this article.